Prognostic significance of thrombocytosis in patients with primary lung cancer - PubMed (original) (raw)
Comparative Study
Prognostic significance of thrombocytosis in patients with primary lung cancer
L M Pedersen et al. Eur Respir J. 1996 Sep.
Free article
Abstract
In patients with malignancies, thrombocytosis has previously been related to disease stage, histological type, and survival. In the present study, the prevalence of thrombocytosis and the prognostic information provided by platelet counts were analysed in a large cohort of patients with primary lung cancer. At the time of diagnosis, pretreatment platelet counts were retrospectively recorded in 1,115 consecutive patients with histologically proven primary lung cancer. All patients were reviewed regarding histological type, tumour, node, metastasis (TNM) classification stage and survival. The prevalence of thrombocytosis in patients with lung cancer was compared with that in a series of 550 consecutive out-patients with benign lung disorders. In 269 surgically resected patients, postoperative platelet counts were recorded 1-3 months after resection of the tumour. In the follow-up period, thromboembolic episodes diagnosed either clinically or at autopsy were recorded. The overall prevalence of thrombocytosis (> 400 x 10(9) platelets.L-1) in the patients with lung cancer was 32%. The frequency of thrombocytosis was significantly higher compared with the control subjects (32 vs 6%; p < 0.0001). Platelet counts differed significantly among subgroups defined by the TNM classification, with the proportion of patients with > 400 x 10(9) platelets.L-1 greatest in the more advanced TNM stages (stage I and II 23% vs stage III and IV 37%; p < 0.0001). Patients with thrombocytosis had a significantly poorer survival than patients with normal platelet counts (p < 0.0001). In a multivariate survival analysis (Cox model), thrombocytosis continued to correlate strongly with poor survival even when adjusted for histological type, sex, age, and TNM stage (p < 0.001). In surgically resected patients, the frequency of preoperative and postoperative thrombocytosis differed significantly (23.0 vs 8.9%; p < 0.0001). Survival rate was significantly reduced in patients with preoperative thrombocytosis (p = 0.005). Thrombocytosis was not associated with an increased incidence of thromboembolism. In conclusion, thrombocytosis is an independent prognostic factor of survival in patients with primary lung cancer. We suggest that platelet counts should be included in future multivariate analyses of survival in patients with lung cancer.
Similar articles
- Prognostic significance of initial platelet counts and fibrinogen level in advanced non-small cell lung cancer.
Kim KH, Park TY, Lee JY, Lee SM, Yim JJ, Yoo CG, Kim YW, Han SK, Yang SC. Kim KH, et al. J Korean Med Sci. 2014 Apr;29(4):507-11. doi: 10.3346/jkms.2014.29.4.507. Epub 2014 Apr 1. J Korean Med Sci. 2014. PMID: 24753697 Free PMC article. - [The prognostic value of thrombocytosis in patients with primary lung cancer].
Pedersen LM, Milman N. Pedersen LM, et al. Ugeskr Laeger. 1998 Jun 22;160(26):3917-20. Ugeskr Laeger. 1998. PMID: 9656833 Danish. - Prognostic impact of thrombocytosis in resectable non-small cell lung cancer.
Tomita M, Shimizu T, Hara M, Ayabe T, Onitsuka T. Tomita M, et al. Interact Cardiovasc Thorac Surg. 2008 Aug;7(4):613-5. doi: 10.1510/icvts.2007.174391. Epub 2008 May 23. Interact Cardiovasc Thorac Surg. 2008. PMID: 18502783 - Preoperative elevated platelet count and thrombocytosis in gynecologic malignancies.
Menczer J. Menczer J. Arch Gynecol Obstet. 2017 Jan;295(1):9-15. doi: 10.1007/s00404-016-4212-9. Epub 2016 Oct 6. Arch Gynecol Obstet. 2017. PMID: 27714462 Review. - Poor prognostic role of the pretreatment platelet counts in colorectal cancer: A meta-analysis.
Rao XD, Zhang H, Xu ZS, Cheng H, Shen W, Wang XP. Rao XD, et al. Medicine (Baltimore). 2018 Jun;97(23):e10831. doi: 10.1097/MD.0000000000010831. Medicine (Baltimore). 2018. PMID: 29879017 Free PMC article. Review.
Cited by
- Platelet release of Vascular Endothelial Growth Factor (VEGF) in patients undergoing chemotherapy for breast cancer.
Kirwan CC, Byrne GJ, Kumar S, McDowell G. Kirwan CC, et al. J Angiogenes Res. 2009 Oct 24;1:7. doi: 10.1186/2040-2384-1-7. J Angiogenes Res. 2009. PMID: 20016693 Free PMC article. - Neutrophil-to-Lymphocyte Ratio Is a Major Prognostic Factor in Non-small Cell Lung Carcinoma Patients Undergoing First Line Immunotherapy With Pembrolizumab.
Romano FJ, Ronga R, Ambrosio F, Arundine D, Longo V, Galetta D, Gridelli C, Maione P, Palma V, Damiano V, Verde A, Giacobbe I, Augurio MR, Iengo G, Chetta M, Tarsitano M, Campione S, Failla G, Raucci A, Riccardi F. Romano FJ, et al. Cancer Diagn Progn. 2023 Jan 3;3(1):44-52. doi: 10.21873/cdp.10178. eCollection 2023 Jan-Feb. Cancer Diagn Progn. 2023. PMID: 36632583 Free PMC article. - Blood Immune Cell Biomarkers in Patient With Lung Cancer Undergoing Treatment With Checkpoint Blockade.
Möller M, Turzer S, Schütte W, Seliger B, Riemann D. Möller M, et al. J Immunother. 2020 Feb/Mar;43(2):57-66. doi: 10.1097/CJI.0000000000000297. J Immunother. 2020. PMID: 31592989 Free PMC article. - Prognostic significance of pretreatment total lymphocyte count and neutrophil-to-lymphocyte ratio in extensive-stage small-cell lung cancer.
Suzuki R, Lin SH, Wei X, Allen PK, Welsh JW, Byers LA, Komaki R. Suzuki R, et al. Radiother Oncol. 2018 Mar;126(3):499-505. doi: 10.1016/j.radonc.2017.12.030. Epub 2018 Feb 2. Radiother Oncol. 2018. PMID: 29398150 Free PMC article. - Prognostic significance of initial platelet counts and fibrinogen level in advanced non-small cell lung cancer.
Kim KH, Park TY, Lee JY, Lee SM, Yim JJ, Yoo CG, Kim YW, Han SK, Yang SC. Kim KH, et al. J Korean Med Sci. 2014 Apr;29(4):507-11. doi: 10.3346/jkms.2014.29.4.507. Epub 2014 Apr 1. J Korean Med Sci. 2014. PMID: 24753697 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical